Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,090.00
-28.40 (-2.54%)
Oct 31, 2025, 3:30 PM IST
Jubilant Pharmova Employees
Jubilant Pharmova had 5,547 employees as of March 31, 2025. The number of employees increased by 148 or 2.74% compared to the previous year.
Employees
5,547
Change (1Y)
148
Growth (1Y)
2.74%
Revenue / Employee
13.73M INR
Profits / Employee
861.19K INR
Market Cap
173.85B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5,547 | 148 | 2.74% |
| Mar 31, 2024 | 5,399 | 1,039 | 23.83% |
| Mar 31, 2023 | 4,360 | -1,465 | -25.15% |
| Mar 31, 2022 | 5,825 | 25 | 0.43% |
| Mar 31, 2021 | 5,800 | -2,200 | -27.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Jubilant Pharmova News
- 23 days ago - Jubilant Pharmova subsidiary launches new high-speed isolator-based line at US facility, adds 50% capacity - Business Upturn
- 3 months ago - Jubilant Pharmova receives 4 observations from USFDA after Pre-Approval Inspection at Roorkee facility - Business Upturn
- 3 months ago - Jubilant Food Share Price Target 2022 - ABC Money
- 4 months ago - QSR sector faces rising competition; CLSA cautious on Jubilant and Westlife, positive on Devyani and RBA - Business Upturn
- 11 months ago - Jubilant to buy 40% in Coke bottler's parent for 10k cr - The Times of India
- 1 year ago - Bernstein maintains Outperform rating on Jubilant Foodworks, highlights three pillars to achieve $10 billion market cap - Business Upturn
- 1 year ago - Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - Benzinga
- 1 year ago - CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside - Business Upturn